[HTML][HTML] Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: a multicenter collaborative …
H Kaku, S Kumagai, H Onoue… - Experimental and …, 2012 - spandidos-publications.com
Paclitaxel/carboplatin chemotherapy for cancer (TC therapy) exhibits neurotoxicity and
causes peripheral neuropathy at a high frequency, which is difficult to cope with. In this …
causes peripheral neuropathy at a high frequency, which is difficult to cope with. In this …
[HTML][HTML] Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky …
T Shoji, E Takatori, Y Furutake, A Takada… - International journal of …, 2016 - Springer
Background We examined the efficacy and safety of neoadjuvant chemotherapy (NAC) with
the CPT-11+ CDDP regimen in combination with radical hysterectomy. Subjects and …
the CPT-11+ CDDP regimen in combination with radical hysterectomy. Subjects and …
Expression of human telomerase reverse transcriptase and correlation with telomerase activity in placentas with and without intrauterine growth retardation
T Izutsu, N Izutsu, A Iwane, A Takada… - Acta obstetricia et …, 2006 - Taylor & Francis
Background. Human telomerase reverse transcriptase has been found in telomerase-
positive tumor tissues, but not in telomerase-negative nonmalignant somatic cells. Methods …
positive tumor tissues, but not in telomerase-negative nonmalignant somatic cells. Methods …
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report
E Takatori, T Shoji, Y Miura, A Takada… - OncoTargets and …, 2014 - Taylor & Francis
A case study using mammalian target of rapamycin complex 1 in recurrent ovarian clear cell
carcinoma (CCC) was recently conducted. We report our experience with a patient suffering …
carcinoma (CCC) was recently conducted. We report our experience with a patient suffering …
Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancer
T Shoji, E Takatori, Y Miura, A Takada, H Omi… - International Journal of …, 2014 - ijgc.bmj.com
Objective Patients with end-stage cancer have poorly controlled ascites retention resulting
due to cancerous peritonitis. We intraperitoneally administered triamcinolone acetonide (TA) …
due to cancerous peritonitis. We intraperitoneally administered triamcinolone acetonide (TA) …
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix
E Takatori, T Shoji, Y Suga, H Niinuma, Y Miura… - International journal of …, 2014 - Springer
Background The efficacy and safety of S-1/oxaliplatin (SOX) therapy in patients with
recurrent adenocarcinoma of the uterine cervix were examined in a pilot study. Patients and …
recurrent adenocarcinoma of the uterine cervix were examined in a pilot study. Patients and …
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell …
E Takatori, T Shoji, A Takada, T Nagasawa… - OncoTargets and …, 2016 - Taylor & Francis
Objective In order to evaluate the usefulness of neoadjuvant chemotherapy (NAC) for stage
II cervical squamous cell carcinoma with a bulky mass, we retrospectively compared patients …
II cervical squamous cell carcinoma with a bulky mass, we retrospectively compared patients …
[HTML][HTML] A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy
E Takatori, T Shoji, Y Miura… - Molecular and …, 2015 - spandidos-publications.com
There are currently no studies demonstrating the effects of palonosetron on delayed
chemotherapy‑induced nausea and vomiting (CINV) in gynecological cancer patients …
chemotherapy‑induced nausea and vomiting (CINV) in gynecological cancer patients …
A phase I/II study of multiple peptides cocktail vaccine for advanced/recurrent ovarian cancer.
S Takeuchi, T Shoji, M Kagabu, T Honda, F Miura… - 2013 - ascopubs.org
TPS3116 Background: Despite improvement in chemotherapy including the molecular
targeting agents, advanced or recurrent ovarian cancer (A/ROC) are still incurable. Some …
targeting agents, advanced or recurrent ovarian cancer (A/ROC) are still incurable. Some …
Phase II Clinical Study of Palonosetron Plus Dexamethasone in Patients with Gynecological Cancers Receiving Tc Therapy
E Takatori, T Shoji, A Takada, M Nagao… - Annals of …, 2014 - annalsofoncology.org
Objecvtive: There have been no reports yet of the effect of palonosetron puls
dexamethasone on delayed chemotherapy-induced nausea and vomiting for gynecological …
dexamethasone on delayed chemotherapy-induced nausea and vomiting for gynecological …